Mark Zitter, MBA, Discusses Implications of Co-Pay Offset Programs for Managed Care

In this video, Mark Zitter, MBA, talks about the implications of Co-Pay Offset Programs for managed care. "Co-pay programs affect managed care very differently depending on the nature of the program," says Zitter. "These programs are tremendously varied."

Related Videos

Related Content

Advertisement

October 22nd 2024

The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret

Laura Joszt, MA

In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.

October 22nd 2024

Engage, Educate, Empower: Transforming Kidney Care

Maggie L. Shaw

In our conversation with Jeff Giullian, MD, MBA, chief medical officer with DaVita Kidney Care, we dive into 4 important aspects of kidney care: prevention, social support, integrated care, and patient support.

October 18th 2024

Population Health Strategies Are Vital for Tackling, Improving CKD Care

Kyle Munz

Navdeep Tangri, MD, PhD, FRCP, University of Manitoba, speaks to the value of population health strategies in clinical approaches to care delivery for patients with chronic kidney disease (CKD).

September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

October 18th 2024

Bimekizumab Poised to Tackle Unmet HS Treatment Needs

Maggie L. Shaw

Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.

October 18th 2024

Expanding Access to NSCLC Innovations: Challenges and Opportunities

Maggie L. Shaw

The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and improving treatment access, in particular for immunotherapy and targeted treatments.

Related Content

Advertisement

October 22nd 2024

The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret

Laura Joszt, MA

In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.

October 22nd 2024

Engage, Educate, Empower: Transforming Kidney Care

Maggie L. Shaw

In our conversation with Jeff Giullian, MD, MBA, chief medical officer with DaVita Kidney Care, we dive into 4 important aspects of kidney care: prevention, social support, integrated care, and patient support.

October 18th 2024

Population Health Strategies Are Vital for Tackling, Improving CKD Care

Kyle Munz

Navdeep Tangri, MD, PhD, FRCP, University of Manitoba, speaks to the value of population health strategies in clinical approaches to care delivery for patients with chronic kidney disease (CKD).

September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

October 18th 2024

Bimekizumab Poised to Tackle Unmet HS Treatment Needs

Maggie L. Shaw

Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.

October 18th 2024

Expanding Access to NSCLC Innovations: Challenges and Opportunities

Maggie L. Shaw

The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and improving treatment access, in particular for immunotherapy and targeted treatments.